Skip to main content

What the label lists and what reports show

Methazolamide side effects

Methazolamide's FDA label lists its adverse reactions in its own words. FAERS holds 339 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is fatigue (41 reports).

  • Generic listed

Check it at the source: the methazolamide FDA label on DailyMed (effective October 23, 2025, Bausch & Lomb Incorporated); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

Adverse reactions, occurring most often early in therapy, include paresthesias, particularly a “tingling” feeling in the extremities; hearing dysfunction or tinnitus; fatigue; malaise; loss of appetite; taste alteration; gastrointestinal disturbances such as nausea, vomiting, and diarrhea; polyuria; and occasional instances of drowsiness and confusion. Metabolic acidosis and electrolyte imbalance may occur. Transient myopia has been reported. This condition invariably subsides upon diminution or discontinuance of the medication. Other occasional adverse reactions include urticaria, melena, hematuria, glycosuria, hepatic insufficiency, flaccid paralysis, photosensitivity, convulsions, and, rarely, crystalluria and renal calculi. Also see PRECAUTIONS: Information for patients for possible reactions common to sulfonamide derivatives. …

Source: FDA drug label, Bausch & Lomb Incorporated, effective October 23, 2025 (SPL set 0c0ba5c7-c53e-4e29-a7ff-48fddc5a9258), via openFDA; the full label on DailyMed

What do FAERS reports show?

339 reports list methazolamide among the medicines taken, each a report of something that happened, not proof the medicine caused it; 28 are coded as a death and 89 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 22 reactions below, 3 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

The 25 most reported reactions

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Methazolamide: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions